Mostrar el registro sencillo del ítem

dc.contributor.authorBurgos-Molina, Antonio Manuel 
dc.contributor.authorGil-Carmona, Luisa
dc.contributor.authorRuiz-Gómez, Miguel José 
dc.date.accessioned2019-01-16T12:39:22Z
dc.date.available2019-01-16T12:39:22Z
dc.date.created2018
dc.date.issued2019-01-16
dc.identifier.urihttps://hdl.handle.net/10630/17164
dc.description.abstractTumor cells can simultaneously acquire resistance against a diverse group of drugs. This phenomenon is called pleotropic resistance or multidrug resistance. This mechanism could explain the tumor resistance observed in chemotherapy treatments with multiple agents. The aim of this work is to study possible mechanisms of cross resistance between Cisplatin and Bleomycin in Saccharomyces cerevisiae.en_US
dc.description.sponsorshipUniversidad de Málaga. Campus de Excelencia Internacional Andalucía Tech.en_US
dc.language.isoengen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectBleomicinaen_US
dc.subjectTumoresen_US
dc.subject.otherCisplatinen_US
dc.subject.otherBleomycinen_US
dc.subject.otherMechanisms of cross resistanceen_US
dc.titleMechanisms of cross resistance between cisplatin and bleomycin in saccharomyces cerevisiaeen_US
dc.typeinfo:eu-repo/semantics/conferenceObjecten_US
dc.centroFacultad de Medicinaen_US
dc.relation.eventtitle16th ASEICA International Congress 2018en_US
dc.relation.eventplaceValencia (España)en_US
dc.relation.eventdate06-08/11/2018en_US
dc.rights.ccAttribution-NonCommercial-NoDerivatives 4.0 Internacional*


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional